Journal of Substance Abuse Treatment

Journal of Substance Abuse Treatment
Title	Journal of Substance Abuse Treatment
Discipline	Addiction medicine
Abbreviation	J. Subst. Abuse Treat.
Publisher	Elsevier
Country	United States
History	1984–present
Frequency	Monthly

Contents

Journal of Substance Abuse Treatment The Journal of Substance Abuse Treatment is a peer-reviewed medical journal publishing research, clinical reports, and policy analyses on treatment for substance use disorders. It serves clinicians, researchers, and policymakers affiliated with institutions such as Johns Hopkins University, Yale University, Harvard Medical School, Columbia University, University of California, San Francisco and agencies including National Institute on Drug Abuse, Substance Abuse and Mental Health Services Administration, World Health Organization, Centers for Disease Control and Prevention, and National Institutes of Health. The journal connects work from treatment settings associated with Mayo Clinic, Massachusetts General Hospital, University of Pennsylvania Health System, Kaiser Permanente, and international programs in United Kingdom, Canada, Australia, Sweden, and Norway.

History

Founded in 1984 amid rising research at institutions like Brown University and University of Michigan, the journal emerged alongside organizations such as American Society of Addiction Medicine, European Monitoring Centre for Drugs and Drug Addiction, Canadian Centre on Substance Use and Addiction, Drug Policy Alliance, and policy developments like the Harrison Narcotics Tax Act debates and later the Controlled Substances Act reform movements. Early issues featured authors from Columbia University, University of Pennsylvania, Stanford University, Duke University School of Medicine, Washington University in St. Louis and collaborations with clinical networks at Veterans Health Administration hospitals. Over decades the journal has reflected shifts catalyzed by events including the HIV/AIDS epidemic, the rise of buprenorphine and methadone treatment research at NIDA-funded centers, and responses to the opioid epidemic coordinated with White House Office of National Drug Control Policy initiatives.

The journal covers randomized trials, observational studies, meta-analyses, program evaluations, and implementation science from settings such as community health centers, clinics affiliated with Johns Hopkins Bloomberg School of Public Health, correctional health units linked to Federal Bureau of Prisons, and military treatment facilities associated with United States Department of Veterans Affairs. Topics include pharmacotherapy trials for agents like naltrexone, methadone, buprenorphine, and behavioral interventions tested at centers including Yale-New Haven Hospital, Rutgers University Behavioral Health Care, University of California, Los Angeles, and University of Washington. The journal also publishes work on co-occurring disorders treated at institutions such as Beth Israel Deaconess Medical Center and Cleveland Clinic, implementation studies from networks like Addiction Technology Transfer Center Network, and policy analyses connecting to legislation such as the Affordable Care Act and international guidelines from World Health Organization and United Nations Office on Drugs and Crime.

Editorial leadership has included editors drawn from academic centers like Columbia University Irving Medical Center, University of Pittsburgh Medical Center, Emory University School of Medicine, University of Minnesota, and Vanderbilt University Medical Center. Published monthly by Elsevier, the journal uses peer review processes common to titles such as The Lancet Psychiatry, JAMA Psychiatry, and Addiction (journal). It accepts original research, systematic reviews, brief reports, and commentaries authored by investigators affiliated with National Academy of Medicine members, investigators funded by National Institute on Alcohol Abuse and Alcoholism, and clinicians from hospital systems including NYU Langone Health and Cedars-Sinai Medical Center. The journal issues special sections and supplements tied to conferences such as the College on Problems of Drug Dependence annual meeting and collaborations with societies like the American Psychological Association and Society for Implementation Research Collaboration.

Articles are abstracted and indexed in major bibliographic services alongside journals like The New England Journal of Medicine and British Medical Journal: listings include databases managed by PubMed, Scopus, Web of Science, PsycINFO, and services used by institutions such as University of Oxford and Cambridge University libraries. Indexing supports citation tracking by entities including Clarivate Analytics and metrics aggregated by platforms used at Stanford University and University of California campuses.

The journal is cited in clinical guidelines produced by bodies like the American Psychiatric Association, World Health Organization, National Institute for Health and Care Excellence, and in policy reports from Office of National Drug Control Policy and Centers for Medicare & Medicaid Services. Its articles inform practice at treatment programs operated by Veterans Health Administration, influence training curricula at Columbia University Teachers College and University of California, San Diego, and are discussed in forums hosted by Society for Prevention Research and International Society of Addiction Medicine. Reception in the fields of addiction medicine and public health has been notable alongside titles such as Addiction and Drug and Alcohol Dependence.

Notable publications include randomized trials of pharmacotherapies originating from research groups at University of Pennsylvania, Yale School of Medicine, and University of California, San Francisco; implementation studies from Brown University and Johns Hopkins University; large cohort analyses tied to datasets from National Survey on Drug Use and Health and registries used by Centers for Disease Control and Prevention. Contributions have shaped practice around medication-assisted treatment protocols developed in collaboration with American Society of Addiction Medicine standards, contingency management programs evaluated at University of Vermont, and integrated care models piloted at Maimonides Medical Center and Montefiore Medical Center.

Category:Addiction medicine journals